Related Experiment Video
Updated: Dec 21, 2025

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Body Mass Index as a Prognostic Factor in Liver Transplantation
Noelia García-Fernández1, Carmen Cepeda-Franco1, Pablo Beltrán-Miranda1
1Section of Hepatobiliary Surgery and Liver Transplantation, Department of General Surgery, Virgen del Rocio University Hospital, Sevilla, Spain.
Recipient body mass index (BMI) impacts liver transplant survival, with higher BMI correlating to decreased long-term survival. However, overweight and obesity did not increase early complications or mortality after liver transplantation.
Area of Science:
- Hepatology and Transplant Surgery
- Obesity Medicine
Background:
- Obesity is a global epidemic linked to increased mortality.
- Understanding recipient factors like body mass index (BMI) is crucial for liver transplantation (LT) outcomes.
Purpose of the Study:
- To investigate the association between recipient BMI and survival and morbidity following liver transplantation.
- To analyze the impact of varying BMI categories on post-LT outcomes.
Main Methods:
- Retrospective cohort study of 825 liver transplant recipients between 2006 and 2018.
- Analysis of donor and recipient variables, including BMI.
- Outcomes assessed included postoperative complications, early mortality, graft loss, and overall survival.
Main Results:
- Overall survival at 5 years was significantly lower in recipients with higher BMI (Obesity: 71%, Overweight: 76%, Normal: 83%; P = .027).
- No significant differences in early mortality rates were observed across BMI groups (Normal: 4.42%, Overweight: 6.5%, Obesity: 5.26%).
- Postoperative complications (hemorrhagic, vascular, biliary, etc.) and re-operation rates did not differ significantly between BMI groups.
Conclusions:
- Increasing recipient BMI is associated with reduced overall survival after liver transplantation.
- Overweight and obesity are not identified as risk factors for early morbidity or mortality in liver transplant recipients.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Kidney Transplant I: Introduction

